Arthroscopic Versus Open Subtalar Arthrodesis for the Treatment of Subtalar Arthritis
ISTA-ASTA RCT
Comparative Analysis of Open Versus Arthroscopic Approaches for Subtalar Arthrodesis in Patients With Subtalar Arthritis
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to compare two surgical approaches for treating symptomatic subtalar arthritis in patients who have failed conservative treatment. The main questions it aims to answer are: What is the fusion rate for each surgical technique? Which technique achieves bony union faster with fewer complications? Researchers will compare arthroscopic subtalar arthrodesis (ASTA) using a combined three-to-four portal approach to open in situ subtalar arthrodesis (ISTA) to see if one technique results in superior fusion rates, faster healing, and better functional outcomes. Participants will: Undergo one of two surgical procedures (either ASTA or ISTA) Attend follow-up visits at 6 weeks, 3 months, 6 months, and 12 months after surgery Have X-rays taken to assess fusion and bone healing Complete pain and function questionnaires at each visit
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2023
CompletedFirst Submitted
Initial submission to the registry
March 14, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedApril 13, 2026
March 1, 2026
2.3 years
March 14, 2026
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Fusion Rate at 6 months
Fusion rate is defined as the proportion of patients achieving successful solid bony union of the subtalar joint. Union is determined using combined clinical and radiographic criteria, including absence of pain on palpation and passive stress, absence of detectable subtalar motion, and presence of continuous trabecular bridging across the posterior facet on plain radiographs or computed tomography when radiographs are inconclusive.
6 months postoperatively
Time to Radiographic Union
Time to radiographic union is defined as the time elapsed from the date of surgery to the first radiographic evidence of continuous trabecular bridging across the subtalar joint fusion interface. Assessment is performed using serial plain radiographs, with computed tomography utilized when findings are equivocal.
Up to 12 months postoperatively
Secondary Outcomes (4)
Change in American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score
Preoperative baseline, 6 months postoperatively, and 12 months postoperatively
Change in Pain Intensity Measured by Visual Analog Scale (VAS)
Preoperative baseline, 6 weeks, 3 months, 6 months, 12 months postoperatively
Change in Short Form-12 (SF-12) Health Survey Scores
Preoperative baseline, 6 months postoperatively, 12 months postoperatively
Complication Rate
Intraoperative through 12 months postoperatively
Study Arms (2)
Arthroscopic Subtalar Arthrodesis (ASTA)
ACTIVE COMPARATORArthroscopic technique using a 4 mm 30° arthroscope in the prone position with a combined three-to-four portal approach (anterolateral sinus tarsi portal, posterolateral portal, posteromedial portal). Includes complete synovectomy, motorized debridement of posterior facet cartilage, subchondral microfracture drilling, and percutaneous screw fixation (two 6.5-7.3 mm cannulated screws) under fluoroscopic guidance.
Open In Situ Subtalar Arthrodesis (ISTA)
EXPERIMENTALOpen in situ subtalar arthrodesis via the lateral sinus tarsi approach performed in the supine position. All residual articular cartilage is removed to bleeding cancellous bone. The subchondral plate is perforated to enhance fusion. Fixation is achieved with two percutaneously inserted cannulated screws under fluoroscopic guidance.
Interventions
Arthroscopic technique using a 4 mm 30° arthroscope in the prone position with a combined three-to-four portal approach (anterolateral sinus tarsi portal, posterolateral portal, posteromedial portal). Includes complete synovectomy, motorized debridement of posterior facet cartilage, subchondral microfracture drilling, and percutaneous screw fixation (two 6.5-7.3 mm cannulated screws) under fluoroscopic guidance.
Lateral sinus tarsi approach performed supine with 4-5 cm oblique incision. Complete cartilage debridement to bleeding cancellous bone, subchondral plate perforation, and percutaneous screw fixation (two cannulated screws) under fluoroscopic guidance.
Eligibility Criteria
You may qualify if:
- Clinically and radiographically confirmed symptomatic subtalar arthritis (post-traumatic, primary osteoarthritis, inflammatory or cured post-infective arthritis, symptomatic talocalcaneal coalition, or isolated subtalar arthrosis secondary to pes planovalgus deformity)
- Failure of an adequate trial of non-operative treatment for a minimum of six months
- Skeletal maturity: patients aged 18 years or older
- Ability and willingness to provide written informed consent and to comply fully with the scheduled postoperative follow-up protocol
You may not qualify if:
- Primary subtalar arthrodesis performed for an acute, displaced intra-articular calcaneal fracture
- Arthrodesis planned in conjunction with other simultaneous ipsilateral hindfoot procedures
- Patients with open physes (skeletal immaturity)
- Indication for a distraction-type arthrodesis requiring structural bone graft
- History of previous or current active infection at the planned operative site
- Previous failed attempt at subtalar arthrodesis
- Presence of significant peripheral vascular disease or other major medical comorbidities precluding safe surgical intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Kasr El Aini Hospitalcollaborator
Study Sites (1)
Cairo university hospitals
Cairo, Cairo Governorate, 4240310, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Helal Hosny Abdulaziz, M.B., B.Ch., M.Sc.
Cairo University
- STUDY CHAIR
Ahmed Samir Bashandy
Cairo University
- STUDY CHAIR
Ahmed Mohamed Khedr
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the inherent nature of the surgical interventions, blinding of the patients and the primary surgeon was not feasible. However, the assessor responsible for collecting postoperative outcome scores was kept blinded to group assignment to minimize detection bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic Surgery Specialist (Doctoral Candidate)
Study Record Dates
First Submitted
March 14, 2026
First Posted
March 20, 2026
Study Start
December 5, 2023
Primary Completion
April 1, 2026
Study Completion
June 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share